Pegylated liposomal irinotecan
- BNF:
- Not listed
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- May 2017
Comments
- NICE TA440 - pegylated liposomal irinotecan in combination with 5-fluorouracil and leucovorin is not recommended for treating pancreatic cancer after gemcitabine (Decision date - May 2017)
- NICE TA1052 - (terminated appraisal) Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (Decision date May 2025)
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
search again
